XML 35 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash Flows From Operating Activities:      
Net Earnings/(Loss) $ 7,014 $ (8,995) $ 3,460
Adjustments to reconcile net earnings/(loss) to net cash provided by operating activities:      
Depreciation and amortization, net 10,686 10,380 1,746
Deferred income taxes (1,393) 983 (924)
Stock-based compensation 583 779 441
Impairment charges 1,207 1,203 199
Pension settlements and amortization 35 43 1,688
Divestiture gains and royalties (684) (699) (1,855)
IPRD charge - MyoKardia acquisition 0 11,438 0
Asset acquisition charges 1,157 1,099 63
Equity investment gains, net (745) (1,228) (275)
Contingent consideration fair value adjustments (542) (1,757) 523
Other adjustments 142 (177) (26)
Changes in operating assets and liabilities:      
Receivables (1,054) (646) 752
Inventories 13 2,672 463
Accounts payable 245 188 229
Rebates and discounts 863 1,189 591
Income taxes payable (1,063) (2,305) 907
Other (257) (115) 228
Net Cash Provided by Operating Activities 16,207 14,052 8,210
Cash Flows From Investing Activities:      
Sale and maturities of marketable debt securities 4,196 6,280 3,809
Purchase of marketable debt securities (5,478) (4,172) (3,961)
Proceeds from sales of equity investment securities 2,579 129 167
Capital expenditures (973) (753) (836)
Divestiture and other proceeds 748 741 15,685
Acquisition and other payments, net of cash acquired (1,610) (13,084) (24,777)
Net Cash Used in Investing Activities (538) (10,859) (9,913)
Cash Flows From Financing Activities:      
Short-term debt obligations, net (160) (267) 131
Issuance of long-term debt 0 6,945 26,778
Repayment of long-term debt (6,022) (2,750) (9,256)
Repurchase of common stock (6,287) (1,546) (7,300)
Dividends (4,396) (4,075) (2,679)
Other 641 542 (53)
Net Cash (Used in)/Provided by Financing Activities (16,224) (1,151) 7,621
Effect of Exchange Rates on Cash, Cash Equivalents and Restricted Cash (102) 111 (9)
Increase in Cash, Cash Equivalents and Restricted Cash (657) 2,153 5,909
Cash, Cash Equivalents and Restricted Cash at Beginning of Year 14,973 12,820 6,911
Cash, Cash Equivalents and Restricted Cash at End of Year $ 14,316 $ 14,973 $ 12,820